Navigation Links
Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care
Date:11/7/2009

ement therapy to be highly effective for the treatment of acute HAE attacks and without it some patients may have sought emergency treatment or deferred treatment altogether."

HAE is a genetic disorder caused by a deficiency of C1-INH and is inherited in an autosomal dominant manner. Symptoms of HAE include episodes of edema or swelling in the face and the abdomen. Patients who have abdominal attacks of HAE can experience episodes of severe pain, diarrhea, nausea, and vomiting caused by swelling of the intestinal wall. HAE attacks that involve the face can cause painful distortion and painful swelling. Diagnosis of HAE requires a blood test to confirm low or abnormal levels of C1-INH. There are estimates of 6,000 to 10,000 or more people with HAE in the U.S.

As part of the same survey, patients could also complete a health-related quality of life (HRQoL) section to compare their opinions about HAE treatment before and after C1-INH. The SF-12 generic measure of health status was supplemented with questions about the effects of C1-INH. Eighteen patients provided HRQoL feedback on 55 attacks with more than 57 percent of respondents reporting very good or excellent general health and 98.1 percent indicating few or no physical health-related limitations on activities. Three-quarters reported no or little pain interference with work and life. About two-thirds reported a positive change in outlook and "much better" feeling of security about treating future attacks.

About I.M.P.A.C.T. 2

Findings of I.M.P.A.C.T. 2 were based on treatment with 20 U/kg bodyweight of C1-INH in 640 episodes of HAE attacks at any body location in 57 patients. The main study end-points were: time to onset of symptom relief; complete resolution of all symptoms; and safety.

The median times to complete resolution of all symptoms were reported as early as 8 hours for laryngeal attack
'/>"/>

SOURCE CSL Behring
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CSL Behring Reaches Primary Endpoint in Clinical Study of C1-INH for Treatment of Hereditary Angioedema
2. Arriva Pharmaceuticals Moves Forward to Phase 2b Development of Lead Inhaled Protein rAAT Replacement Therapy for Hereditary Emphysema
3. CSL Behring Submits BLA Requesting Approval of C1-Esterase Inhibitor for the Treatment of Hereditary Angioedema
4. ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
5. FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE)
6. Changing Paradigms in Hereditary Angioedema: A Focus on Prompt Diagnosis and New Therapies
7. CSL Behring Announces FDA Approval of Berinert(R), First and Only Therapy Approved for the Treatment of Acute Abdominal and Facial Attacks of Hereditary Angioedema in U.S.
8. Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... ReportsnReports.com adds Global Medical ... forecasts as well as Global Medical Simulation Market ... collection of its library. Complete 2015 ... spread across 164 pages, talking about 7 major ... is now available at http://www.reportsnreports.com/reports/407046-global-medical-simulation-industry-report-2015.html . ...
(Date:8/3/2015)... , Aug. 3, 2015 OmniSeq, LLC ... Institute to the OmniSeq SM Genomic Network.  ... Cancer Institute (RPCI) and announced it was making ... a physician-driven, collaborative approach to genomic diagnostics that ... Cancer Institute is a rapidly expanding, multidisciplinary cancer ...
(Date:8/3/2015)... Aug. 3, 2015 Ortho Clinical Diagnostics (OCD) ... named Chief Corporate Brand and Communications Officer, effective immediately. ... team, Bouryal will lead the company,s worldwide corporate brand ... transition to an independent company by adding sites in ... and Chief Executive Officer Dr. Martin Madaus . ...
Breaking Medicine Technology:Medical Simulation Market to see 14% CAGR to 2019 2Medical Simulation Market to see 14% CAGR to 2019 3Medical Simulation Market to see 14% CAGR to 2019 4Medical Simulation Market to see 14% CAGR to 2019 5Medical Simulation Market to see 14% CAGR to 2019 6OmniSeq Adds Wilmot Cancer Institute to its Collaboration-Based Treatment Network 2OmniSeq Adds Wilmot Cancer Institute to its Collaboration-Based Treatment Network 3Ortho Clinical Diagnostics Appoints Kristie Bouryal Chief Corporate Brand and Communications Officer 2
(Date:8/4/2015)... WI (PRWEB) , ... August 04, 2015 , ... Many ... video on the subject, Renew Man™ is standing up as a voice of authority ... veteran of the healthy aging industry with special experience and expertise in the safe ...
(Date:8/4/2015)... Columbus, Ohio (PRWEB) , ... August 04, 2015 ... ... schoolchildren have up-to-date immunizations, especially those entering kindergarten. All required immunizations are covered ... exclusion rules, which means that children who aren’t caught up with their immunizations ...
(Date:8/4/2015)... ... 04, 2015 , ... SanusEO, the healthcare industry innovator of ... leadership team as Senior Vice President of Sales and Marketing. Mr. McCalley brings ... markets with a special emphasis on the healthcare industry. , Today, patients are ...
(Date:8/4/2015)... ... August 04, 2015 , ... T.E.N., an information technology and security ... The ISE® Lions’ Den and Jungle Lounge 2015, which will be held from 3-6:30 ... During the event, eight emerging security vendors, known as “Gazelles,” will go head-to-head with ...
(Date:8/4/2015)... Port Washington, NY (PRWEB) , ... August 04, ... ... the 2015 Midyear Channel Report, finds the North America IT reseller channel will ... and profitability at rates ahead of their 2014 pace and greater than their ...
Breaking Medicine News(10 mins):Health News:New Video from Renew Man™ Raises Awareness of the Right Way to Correct Low Testosterone 2Health News:New Video from Renew Man™ Raises Awareness of the Right Way to Correct Low Testosterone 3Health News:Buckeye Health Plan Reminds Parents to Keep Immunizations In Mind As School Year Kicks Off 2Health News:SanusEO Hires Healthcare Technology Executive Bruce McCalley As Senior Vice President of Sales & Marketing 2Health News:SanusEO Hires Healthcare Technology Executive Bruce McCalley As Senior Vice President of Sales & Marketing 3Health News:T.E.N. Releases Pitch Schedule for The ISE® Lions Den & Jungle Lounge 2015 2Health News:T.E.N. Releases Pitch Schedule for The ISE® Lions Den & Jungle Lounge 2015 3Health News:T.E.N. Releases Pitch Schedule for The ISE® Lions Den & Jungle Lounge 2015 4Health News:The 2112 Group Forecasts North America IT Channel to Grow At Least 6% in 2015 2Health News:The 2112 Group Forecasts North America IT Channel to Grow At Least 6% in 2015 3
... this has been a jolly, good year for Dr. Bhimu ... Fruit Improvement Center has been named a fellow by three ... and industry. The title of "fellow" is bestowed by ... to research and academia. Patil was first honored in ...
... Includes Demonstration of Robotically Assisted Heart Valve Repair , ... Today, President Barack Obama visited Cleveland Clinic for an inside ... and a demonstration in the operating room. The visit gave the president ... results. , , The president,s tour included ...
... ... , ... (Vocus) July 22, 2009 -- With almost 20 billion dollars recently earmarked to encourage ... use of the Certified (EHR)" in its testimony to the National Committee on Vital ...
... , , , ... Debra R. Lappin, a nationally recognized strategist in public health and science ... http://www.newscom.com/cgi-bin/prnh/20090325/DC89081LOGO ) , , ... in health and science policy, leading a major patient advocacy organization and ...
... stem cells escape detection by co-opting a protective molecular badge ... the body, according to a pair of studies by researchers ... ,Don,t eat me signal," said Ravindra Majeti, MD, PhD, assistant ... author of one of the studies, which focused on acute ...
... are hoping to find out if inflammation of the knee ... which leads to pain, stiffness, swelling and disability. Up ... in the knee. Now 200 patients, over the age ... part in a study led by research physiotherapist Michelle Hall ...
Cached Medicine News:Health News:Patil: For he's a jolly good science fellow 2Health News:President Obama's Visit to Cleveland Clinic Provides Look at High-Quality, Cost-Effective Healthcare Delivery Model 2Health News:President Obama's Visit to Cleveland Clinic Provides Look at High-Quality, Cost-Effective Healthcare Delivery Model 3Health News:Health Story Project Offers Perspective on "Meaningful Use" Definition 2Health News:Health Story Project Offers Perspective on "Meaningful Use" Definition 3Health News:Health Story Project Offers Perspective on "Meaningful Use" Definition 4Health News:Council for American Medical Innovation Names Debra R. Lappin President 2Health News:Council for American Medical Innovation Names Debra R. Lappin President 3Health News:Leukemia cells evade immune system by mimicking normal cells, Stanford studies show 2Health News:Leukemia cells evade immune system by mimicking normal cells, Stanford studies show 3Health News:Leukemia cells evade immune system by mimicking normal cells, Stanford studies show 4Health News:Detecting early signs of osteoarthritis 2
... adjusted for perfect focus where it's needed ... This, along with Keeler's wide angle light ... the patient's pupil size, you will see ... Lithium-ion technology provides a longer life battery ...
... ophthalmoscopes are individually adjusted for perfect focus ... not on paper. This, along with Keeler's ... ensures that whatever the patient's pupil size, ... field of view. Lithium-ion technology provides a ...
The Beta 200S combines Heine's patented aspherical optics (U.S. Pat. 4.963.014) and a single-step Rekoss disk with a range of 36 to +38 dpt. to provide perfectly-focused images even in cases of high ...
A full function instrument at an economical price....
Medicine Products: